First Light Asset Management’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Sell
313,906
-555,770
-64% -$23.9M 1.13% 28
2025
Q4
$44M Buy
869,676
+362,579
+72% +$12.9M 3.37% 8
2025
Q3
$14.7M Sell
507,097
-55,884
-10% -$1.29M 1.39% 27
2025
Q2
$13.3M Sell
562,981
-612,898
-52% -$13.8M 1.72% 20
2025
Q1
$28.2M Sell
1,175,879
-85,367
-7% -$2.74M 3.23% 12
2024
Q4
$53.3M Buy
1,261,246
+556,012
+79% +$24.6M 5.1% 6
2024
Q3
$31.2M Sell
705,234
-300,489
-30% -$11.4M 2.59% 20
2024
Q2
$36.4M Buy
1,005,723
+569,590
+131% +$22.6M 3.19% 15
2024
Q1
$18.8M Buy
+436,133
New +$15.5M 1.44% 30

Other funds holding VERA

First Light Asset Management's VERA Position: Q1 2026 in Review

First Light Asset Management reduced its Vera Therapeutics (VERA) stake by 64% in Q1 2026, selling an estimated $23.9M and leaving 313,906 shares worth $12.6M. The position accounts for 1.13% of the portfolio, ranked #28.

First Light Asset Management first reported a position in VERA in Q1 2024 and has held it in 9 quarters since. The position peaked at $53.3M in Q4 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • First Light Asset Management held 313,906 shares of Vera Therapeutics worth $12.6M as of Q1 2026.
  • First Light Asset Management sold 555,770 Vera Therapeutics shares in Q1 2026, an estimated $23.9M.
  • Vera Therapeutics made up 1.13% of First Light Asset Management's portfolio in Q1 2026, its #28 holding.
  • First Light Asset Management first reported a position in Vera Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • First Light Asset Management's Vera Therapeutics position peaked at $53.3M in Q4 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on First Light Asset Management's 13F filing for Q1 2026, filed 15 May 2026.